TABLE 3

Uptake kinetic parameters of seven OATP substrates estimated in rat hepatocytes by using a two-compartment mechanistic model

Uptake kinetics was measured in freshly isolated rat hepatocytes plated for 2 h over 2 or 45–90 min at 10 concentrations (0.1–300 μM). Data represent mean of three experiments ± S.D.

DrugKm,uaVmaxPdiff,uafucellCLactive,uaMaximal Proportion of Active Transport
μMpmol/min/106 cellsμl/min/106 cellsμl/min/106 cells%
Bosentan
    2 min14.2 ± 1.1883 ± 1086.75 ± 0.640.104 ± 0.02262.1 ± 3.890.2 ± 0.5
    60 min6.448813.50.09676.685.0
Pitavastatin
    2 min11.6 ± 2.11055 ± 1538.12 ± 2.420.031 ± 0.03395.4 ± 34.491.4 ± 4.0
    90 min6.374710.90.05311991.6
Pravastatin
    2 min37.0 ± 20.1500 ± 4120.358 ± 0.2981.0 ± 0.012.5 ± 4.197.4 ± 1.4
    45 min23.42231.290.7789.588.0
Repaglinide
    2 min28.0 ± 17.21393 ± 9344.49 ± 3.820.386 ± 0.53848.8 ± 2.892.0 ± 6.8
    45 min8.858624.00.05066.373.4
Rosuvastatin
    2 min14.6 ± 1.81218 ± 970.855 ± 0.4590.507 ± 0.43083.8 ± 6.899.0 ± 0.6
    45 min11.29781.010.47787.698.9
Telmisartan
    2 min3.41 ± 1.95337 ± 20221.4 ± 16.00.010 ± 0.00998.8 ± 43.580.9 ± 12.4
    90 min2.3216022.50.02468.775.3
Valsartan
    2 min6.38 ± 0.95159 ± 700.184 ± 0.1181.0 ± 0.026.4 ± 15.299.2 ± 0.5
    90 min2.71170.371.043.399.1
  • a Parameters are expressed relative to unbound media drug concentration.